alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**EXHIBIT 32**

** **

**CERTIFICATION OF CHIEF EXECUTIVE OFFICERAND CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350,**

**AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

** **

In connection with the EMRISE Corporation’s (the “Company”) Quarterly Report on Form 10-Qfor the period ended September 30, 2009 (the “Report”), the undersignedhereby certify in their capacities as Chief Executive Officer and ChiefFinancial Officer of the Company, respectively, pursuant to 18 U.S.C.section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Actof 2002, that:

 

1.             theReport fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934, as amended; and

 

2.             theinformation contained in the Report fairly presents, in all material respects,the financial condition and results of operations of the Company.

 
| Dated: November 16, 2009 | By:    | /s/ CARMINE T. OLIVA                                   |
|-------------------------------|--------|--------------------------------------------------------|
|                          |   | Carmine T. Oliva                                       |
|                          |   | Chief Executive Officer (principal executive  officer) |
|                          |   |                                                   |
|                          |   |                                                   |
| Dated: November 16, 2009 | By:    | /s/ D. JOHN DONOVAN                                    |
|                          |   | D. John Donovan                                        |
|                          |   | Chief Financial Officer (principal financial  officer) |

 

*A signed original of this written statement required by Section 906,or other document authenticating, acknowledging, or otherwise adopting the signaturesthat appear in typed form within the electronic version of this writtenstatement required by Section 906, has been provided to the Company andwill be retained by the Company and furnished to the Securities and ExchangeCommission or its staff upon request.*

 

----
Docket No: FAA - 2015 - 1279 Dir ID: 2014 - NM - 049 - AD
# C_2015034EN.01000802.xml

| 2.2.2015 | EN | Official Journal of the European Union | C 34/8 |
| --- | --- | --- | --- |

2.2.2015

EN

Official Journal of the European Union

C 34/8

---

Request for a preliminary ruling from the Tribunale ordinario di Torino (Italy) lodged on 7 November 2014 — Criminal proceedings against Stefano Burzio

(Case C-497/14)

(2015/C 034/08)

Language of the case: Italian

Referring court

Referring court

Tribunale ordinario di Torino

Party to the main proceedings

Party to the main proceedings

Stefano Burzio

Question referred

Question referred

On a proper construction of Article 4 of [Protocol No 7 to the European Convention on the Protection of Human Rights and Fundamental Freedoms] and Article 50 [of the Charter of Fundamental Rights of the European Union], is the provision made under Article 10a of Legislative Decree No 74 [of 10 March 2000] consistent with Community law, in so far as it permits the criminal liability of a person on whom an irreversible administrative penalty under Article 13(1) of Legislative Decree No 471 [of 18 December 1997] has already been imposed (through the application of a surtax) to be assessed in respect of the same act or omission (non-payment of withholding tax)?

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Treasury

###### Internal Revenue Service

# AGENCY:

Internal Revenue Service (IRS), Treasury.

# ACTION:

Notice of meeting.

# SUMMARY:

An open meeting of the Area 6 Taxpayer Advocacy Panel will be conducted. The Taxpayer Advocacy Panel is soliciting public comment, ideas, and suggestions on improving customer service at the Internal Revenue Service.

# DATES:

The meeting will be held Tuesday, April 6, 2010.

# FOR FURTHER INFORMATION CONTACT:

Janice Spinks at 1-888-912-1227 or 206-220-6098.

# SUPPLEMENTARY INFORMATION:

                    Notice is hereby given pursuant to Section 10(a)(2) of the Federal Advisory Committee Act, 5 U.S.C. App. (1988) that an open meeting of the Area 6 Taxpayer Advocacy Panel will be held Tuesday, April 6, 2010, at 1 p.m. Pacific Time via telephone conference. The public is invited to make oral comments or submit written statements for consideration. Due to limited conference lines, notification of intent to participate must be made with Janice Spinks. For more information, please contact Ms. Spinks at 1-888-912-1227 or 206-220-6098, or write TAP Office, 915 2nd Avenue, MS W-406, Seattle, WA 98174 or post comments to the Web site:                     *http://www.improveirs.org.*

The agenda will include various IRS issues.

Dated: March 3, 2010.

Shawn F. Collins,

Acting Director, Taxpayer Advocacy Panel.

[FR Doc. 2010-4888 Filed 3-8-10; 8:45 am]

BILLING CODE 4830-01-P
Editorial Note on Part 868
Editorial Note: Nomenclature changes to part 868 appear at 73 FR 35341, June 23, 2008.

§ 868.5165 Nitric oxide administration apparatus. ( a ) *Identification.* The nitric oxide administration apparatus is a device used to add nitric oxide to gases that are to be breathed by a patient. The nitric oxide administration apparatus is to be used in conjunction with a ventilator or other breathing gas administration system.
( b ) *Classification.* Class II. The special control for this device is FDA's “Guidance Document for Premarket Notification Submissions for Nitric Oxide Administration Apparatus, Nitric Oxide Analyzer, and Nitrogen Dioxide Analyzer.”
[65 FR 11465, Mar. 3, 2000]
#### § 1.1382-4 Taxable income of cooperatives; payment period for each taxable year.

The payment period for a taxable year is the period beginning with the first day of such taxable year and ending with the fifteenth day of the ninth month following the close of such year.

[T.D. 6643, 28 FR 3156, Nov. 26, 1963]
Editorial Note on Part 878
Editorial Note: Nomenclature changes to part 878 appear at 73 FR 35341, June 23, 2008.

§ 878.4040 Surgical apparel. ( a ) *Identification.* Surgical apparel are devices that are intended to be worn by operating room personnel during surgical procedures to protect both the surgical patient and the operating room personnel from transfer of microorganisms, body fluids, and particulate material. Examples include surgical caps, hoods, masks, gowns, operating room shoes and shoe covers, and isolation masks and gowns. Surgical suits and dresses, commonly known as scrub suits, are excluded.
( b ) *Classification.* ( 1 ) Class II (special controls) for surgical gowns and surgical masks. A surgical N95 respirator or N95 filtering facepiece respirator is not exempt if it is intended to prevent specific diseases or infections, or it is labeled or otherwise represented as filtering surgical smoke or plumes, filtering specific amounts of viruses or bacteria, reducing the amount of and/or killing viruses, bacteria, or fungi, or affecting allergenicity, or it contains coating technologies unrelated to filtration (e.g., to reduce and or kill microorganisms). Surgical N95 respirators and N95 filtering facepiece respirators are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9, and the following conditions for exemption: ( i ) The user contacting components of the device must be demonstrated to be biocompatible.
( ii ) Analysis and nonclinical testing must: ( A ) Characterize flammability and be demonstrated to be appropriate for the intended environment of use; and
( B ) Demonstrate the ability of the device to resist penetration by fluids, such as blood and body fluids, at a velocity consistent with the intended use of the device.
( iii ) NIOSH approved under its regulation.
( 2 ) Class I (general controls) for surgical apparel other than surgical gowns and surgical masks. The class I device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 878.9.
[53 FR 23872, June 24, 1988, as amended at 65 FR 2317, Jan. 14, 2000; 83 FR 22848, May 17, 2018]
Exhibit 32.1

# Written Statement of
the Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C.
§1350

Solely
for the purposes of complying with 18 U.S.C. §1350, as adopted pursuant to Section
906 of the Sarbanes-Oxley Act of 2002, we, the undersigned President and Chief Executive
Officer and Vice President Law/Finance and Secretary of Ladish Co., Inc. (the
Company), hereby certify, based on our knowledge, that the Report on Form 10-Q
of the Company for the quarter ended March 31, 2008 (the Report) fully
complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and
that information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.

/s/ Kerry L. Woody  
Kerry L. Woody President and Chief
Executive Officer

/s/ Wayne E. Larsen  
Wayne E. Larsen Vice President
Law/Finance & Secretary

April 29, 2008
NOT FINAL UNTIL TIME EXPIRES TO FILE REHEARING MOTION AND, IF FILED, DETERMINED

IN THE DISTRICT COURT OF APPEAL OF FLORIDA SECOND DISTRICT

SKYRA LANCE HARPER, ) ) Appellant, ) ) v. ) Case No. 2D19-2466 ) STATE OF FLORIDA, ) ) Appellee. ) ) Opinion filed September 2, 2020. Appeal from the Circuit Court for Hillsborough County; Thomas P. Barber, Judge. Howard L. Dimmig, II, Public Defender and Susan M. Shanahan, Assistant Public Defender, Bartow, for Appellant. Ashley Moody, Attorney General, Tallahassee, and Katherine Coombs Cline, Assistant Attorney General, Tampa, for Appellee.

PER CURIAM.

Affirmed.

KHOUZAM, C.J., NORTHCUTT, and KELLY, JJ., Concur.
Editorial Note on Part 880
Editorial Note: Nomenclature changes to part 880 appear at 73 FR 35341, June 23, 2008.

§ 880.6960 Irrigating syringe. ( a ) *Identification.* An irrigating syringe is a device intended for medical purposes that consists of a bulb or a piston syringe with an integral or a detachable tube. The device is used to irrigate, withdraw fluid from, or instill fluid into, a body cavity or wound.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 880.9. If the device is not labeled or otherwise represented as sterile, it is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[45 FR 69682, Oct. 21, 1980, as amended at 66 FR 38807, July 25, 2001]
#### Marguerite L. Nowell *v.*Ames Nowell

*William C. Strong*and *John J. Sullivan,*in support of the motion.

Submitted October 9

decided October 23, 1968

The motion by the defendant for permission to amend his assignment of errors in the appeal from the Superior Court in Fairfield County is denied.
Editorial Note on Part 886
Editorial Note: Nomenclature changes to part 886 appear at 73 FR 35341, June 23, 2008.

§ 886.5800 Ophthalmic bar reader. ( a ) *Identification.* An ophthalmic bar reader is a device that consists of a magnifying lens intended for use by a patient who has impaired vision. The device is placed directly onto reading material to magnify print.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 886.9. The device is also exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
[52 FR 33355, Sept. 2, 1987, as amended at 53 FR 35607, Sept. 14, 1988; 66 FR 38814, July 25, 2001]
#### B. J. HOLLEMAN et al *v.*Geraldine FOWLER

5-5267

454 S. W. 2d 100

Opinion delivered May 25, 1970

*Comer Boyett, Jr.,*for appellants.

*810
      *Lightle & Tedder,*for appellee.

George Rose Smith, Justice.

This appears to be a suit by the appellee to recover judgment upon a $30,-000 note and to impress a constructive trust upon certain land. The chancellor granted the money judgment but refused to enforce the asserted trust. The appellants gave notice of appeal and filed a two-volume record in this court, but they have not submitted an abstract or a brief. As to them the decree must be affirmed under our Rule 10.

The appellee filed notice of cross appeal and has submitted a brief urging that the chancellor erred in refusing to declare a constructive trust. The appellee, however, has not abstracted that part of the record pertinent to her cross appeal, as she should have done. *Terry*v. *Klein,*133 Ark. 363, 201 S. W. 801 (1918). It being impossible for all the seven judges to examine the record, we have no choice except to affirm the decree on cross appeal as well. *Insured Lloyds*v. *Ahrend,*245 Ark. 225, 431 S. W. 2d 740 (1968).

Affirmed.
<TABLE> <S> <C>

<ARTICLE> CT
<CIK> 0000815024
<NAME> AMERICAN AFFORDABLE HOUSING II LIMITED PARTNERSHIP

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-2000
<PERIOD-START>                             APR-01-1999
<PERIOD-END>                               DEC-31-1999
<TOTAL-ASSETS>                               2,453,216
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 2,453,216
<TOTAL-REVENUES>                                  5668
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (510,634)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (504,966)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                      26,200,000
<SECURITIES>                                         0
<RECEIVABLES>                               42,700,000
<ALLOWANCES>                                         0
<INVENTORY>                                 50,700,000
<CURRENT-ASSETS>                           131,100,000
<PP&E>                                   1,132,900,000
<DEPRECIATION>                             432,400,000
<TOTAL-ASSETS>                             834,900,000
<CURRENT-LIABILITIES>                      172,800,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                  1,800,000
<COMMON>                                       900,000
<OTHER-SE>                                 253,100,000
<TOTAL-LIABILITY-AND-EQUITY>               834,900,000
<SALES>                                    137,200,000
<TOTAL-REVENUES>                           137,200,000
<CGS>                                       83,000,000
<TOTAL-COSTS>                              134,700,000
<OTHER-EXPENSES>                           (5,400,000)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                          18,600,000<F1>
<INCOME-PRETAX>                           (10,700,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (10,700,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                           (11,500,000)
<CHANGES>                                            0
<NET-INCOME>                              (22,200,000)
<EPS-PRIMARY>                                    (.23)
<EPS-DILUTED>                                    (.23)
<FN>
<F1>NET OF INTEREST INCOME OF $0.5 MILLION.
</FN>
        

</TABLE>
# C_2014372EN.01002201.xml

| 20.10.2014 | EN | Official Journal of the European Union | C 372/22 |
| --- | --- | --- | --- |

20.10.2014

EN

Official Journal of the European Union

C 372/22

---

Action brought on 11 August 2014 — Bena Properties v Council

(Case T-602/14)

2014/C 372/27

Language of the case: French

Parties

Parties

Applicant: Bena Properties Co. SA (Damascus, Syria) (represented by: E. Ruchat and C. Corent d’Elzius, lawyers)

Applicant:

Defendant: Council of the European Union

Defendant:

Form of order sought

Form of order sought

The applicant claims that the General Court should:

| — | declare the applicant’s action admissible and well founded; |
| --- | --- |

—

declare the applicant’s action admissible and well founded;

| — | consequently, annul Decision 2014/309/CFSP of 28 May 2014 and its subsequent implementing measures, to the extent that they concern the applicant; |
| --- | --- |

—

consequently, annul Decision 2014/309/CFSP of 28 May 2014 and its subsequent implementing measures, to the extent that they concern the applicant;

| — | order the Council of the European Union to pay the costs of the proceedings. |
| --- | --- |

—

order the Council of the European Union to pay the costs of the proceedings.

Pleas in law and main arguments

Pleas in law and main arguments

In support of the action, the applicant relies on three pleas in law that are in essence identical or similar to those relied on in Case T-432/11 Makhlouf v Council
   (1).

Makhlouf v Council

1

---

(1)  OJ C 290, p. 13.

1

---
Editorial Note on Part 870
Editorial Note: Nomenclature changes to part 870 appear at 73 FR 35341, June 23, 2008.

§ 870.5925 Automatic rotating tourniquet. ( a ) *Identification.* An automatic rotating tourniquet is a device that prevents blood flow in one limb at a time, which temporarily reduces the total blood volume, thereby reducing the normal workload of the heart.
( b ) *Classification.* Class II (performance standards).
Editorial Note on Part 862
Editorial Note: Nomenclature changes to part 862 appear at 73 FR 35341, June 23, 2008.

§ 862.1520 5′-Nucleotidase test system. ( a ) *Identification.* A 5′-nucleotidase test system is a device intended to measure the activity of the enzyme 5′-nucleotidase in serum and plasma. Measurements of 5′-nucleotidase are used in the diagnosis and treatment of liver diseases and in the differentiations between liver and bone diseases in the presence of elevated serum alkaline phosphatase activity.
( b ) *Classification.* Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to § 862.9.
[52 FR 16122, May 1, 1987, as amended at 65 FR 2307, Jan. 14, 2000]
**Exhibit 34.3**

**CURCIO**

**+COHEN**

**Report of Independent Registered Public Accounting Firm**

Managing Member 

Park Bridge Lender Services LLC 

New York, NY 

We have examined management’s assertion,included in the accompanying Management’s Report on Assessment of 2016 Compliance by Park Bridge Lender Services LLC with Regulation AB Servicing Criteria (“Management’s Report”), that Park Bridge Lender Services LLC (the“Company”) complied with the servicing criteria set forth in Item 1122(d) of the U.S. Securities and Exchange Commission’s Regulation AB as of and for the year ended December 31, 2016, excluding those criteria noted as notapplicable (N/A) within Exhibit B to Management’s Report. The transactions covered by this report are only those transactions processed by the Company in its capacity as trust advisor or operating advisor for the asset backed securitiestransactions (the “Platform”) identified in Management’s Report. Reference Exhibit A to Management’s Report for the transactions covered by this examination. Management is responsible for the Company’s compliance with theapplicable servicing criteria. Our responsibility is to express an opinion on management’s assertion based on our examination. 

Our examination wasconducted in accordance with attestation standards of the Public Company Accounting Oversight Board (United States) and, accordingly, included examining, on a test basis, evidence about the Company’s compliance with the applicable servicingcriteria and performing such other procedures as we considered necessary in the circumstances. Our examination included testing of a selected sample of the servicing activities related to the Platform, determining whether the Company performed thoseselected activities in compliance with the applicable servicing criteria during the specified period. Our procedures were limited to the selected transactions and servicing activities performed by the Company during the period covered by thisreport. Our examination was not designed to detect material noncompliance arising from errors that may have occurred prior to or subsequent to our tests, that may have affected the Company’s servicing activities during the period covered bythis report. We believe that our examination provides a reasonable basis for our opinion. Our examination does not provide a legal determination on the Company’s compliance with the applicable servicing criteria. 

In our opinion, management’s assertion that the Company complied with the aforementioned applicable servicing criteria identified in Exhibit B toManagement’s Report with respect to the transactions identified in Exhibit A to Management’s Report as of and for the year ended December 31, 2016, for the Platform, is fairly stated in all material aspects. 

/s/ Curcio & Cohen, CPA’s, P.C. 

New York, NY

February 2, 2017 

 
CERTIFIED PUBLICACCOUNTANTS PC 7 PENN PLAZA, SUITE 1500 NEW YORK NY 10001 

TEL: 212 557-9800 FAX: 212 557 9819    WEBSITE:WWW.CWCCPAFIRM.COM